Given that SHBG may be a potential biomarker for insulin resistance in PCOS (Deswal et al., 2018), more research on the natural history evidence and impact on biochemical hyperandrogenism as a diagnostic feature in PCOS is needed. This evidence concerns the gene SHBG and polycystic ovary syndrome.